Obesity, M&A, Biotech Resurgence: A 2026 Guide to Health Stocks

The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is changing....

Redirecting to full article...